ZA948169B - Peptidyl derivatives and processes for their preparation - Google Patents

Peptidyl derivatives and processes for their preparation

Info

Publication number
ZA948169B
ZA948169B ZA948169A ZA948169A ZA948169B ZA 948169 B ZA948169 B ZA 948169B ZA 948169 A ZA948169 A ZA 948169A ZA 948169 A ZA948169 A ZA 948169A ZA 948169 B ZA948169 B ZA 948169B
Authority
ZA
South Africa
Prior art keywords
pct
derivatives
processes
preparation
sec
Prior art date
Application number
ZA948169A
Other languages
English (en)
Inventor
John Richard Morphy
Thomas Andrew Millicam
Original Assignee
Celltech Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939308696A external-priority patent/GB9308696D0/en
Priority to DE69419473T priority Critical patent/DE69419473T2/de
Priority to EP94913709A priority patent/EP0648205B1/en
Priority to ES94913709T priority patent/ES2134939T3/es
Priority to AT94913709T priority patent/ATE182137T1/de
Priority to CA002139128A priority patent/CA2139128A1/en
Priority to PCT/GB1994/000895 priority patent/WO1994025434A1/en
Priority to JP6524026A priority patent/JPH08500124A/ja
Priority to AU65753/94A priority patent/AU6575394A/en
Priority to US08/356,315 priority patent/US5714491A/en
Application filed by Celltech Therapeutics Ltd filed Critical Celltech Therapeutics Ltd
Priority to ZA948169A priority patent/ZA948169B/xx
Publication of ZA948169B publication Critical patent/ZA948169B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/38—Eight-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
ZA948169A 1993-04-27 1994-10-18 Peptidyl derivatives and processes for their preparation ZA948169B (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US08/356,315 US5714491A (en) 1993-04-27 1994-04-27 Peptidyl derivatives as metalloproteinase inhibitors
EP94913709A EP0648205B1 (en) 1993-04-27 1994-04-27 Peptidyl derivatives as metalloproteinase inhibitors
ES94913709T ES2134939T3 (es) 1993-04-27 1994-04-27 Derivados de peptidilo como inhibidores de metaloproteinas.
AT94913709T ATE182137T1 (de) 1993-04-27 1994-04-27 Peptidylderivate als inhibitoren von metalloproteinase
CA002139128A CA2139128A1 (en) 1993-04-27 1994-04-27 Peptidyl derivatives as metalloproteinase inhibitors
DE69419473T DE69419473T2 (de) 1993-04-27 1994-04-27 Peptidylderivate als inhibitoren von metalloproteinase
PCT/GB1994/000895 WO1994025434A1 (en) 1993-04-27 1994-04-27 Peptidyl derivatives as metalloproteinase inhibitors
JP6524026A JPH08500124A (ja) 1993-04-27 1994-04-27 メタロプロテイナーゼインヒビターとしてのペプチジル誘導体
AU65753/94A AU6575394A (en) 1993-04-27 1994-04-27 Peptidyl derivatives as metalloproteinase inhibitors
ZA948169A ZA948169B (en) 1993-04-27 1994-10-18 Peptidyl derivatives and processes for their preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939308696A GB9308696D0 (en) 1993-04-27 1993-04-27 Peptidyl derivatives
ZA948169A ZA948169B (en) 1993-04-27 1994-10-18 Peptidyl derivatives and processes for their preparation

Publications (1)

Publication Number Publication Date
ZA948169B true ZA948169B (en) 1996-04-18

Family

ID=26302820

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA948169A ZA948169B (en) 1993-04-27 1994-10-18 Peptidyl derivatives and processes for their preparation

Country Status (10)

Country Link
US (1) US5714491A (ja)
EP (1) EP0648205B1 (ja)
JP (1) JPH08500124A (ja)
AT (1) ATE182137T1 (ja)
AU (1) AU6575394A (ja)
CA (1) CA2139128A1 (ja)
DE (1) DE69419473T2 (ja)
ES (1) ES2134939T3 (ja)
WO (1) WO1994025434A1 (ja)
ZA (1) ZA948169B (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037472A (en) * 1993-11-04 2000-03-14 Syntex (U.S.A.) Inc. Matrix metalloprotease inhibitors
GB2315750B (en) * 1994-01-22 1998-07-01 British Biotech Pharm Metalloproteinase inhibitors
KR970700652A (ko) * 1994-01-22 1997-02-12 포올 리틀우드 금속단백질 분해효소 억제제
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors
US5917090A (en) * 1995-06-30 1999-06-29 British Biotech Pharmaceuticals Ltd. Matrix metalloproteinase inhibitors
NZ322553A (en) 1995-11-23 1998-12-23 British Biotech Pharm Metalloproteinase inhibitors
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
ATE225343T1 (de) * 1995-12-20 2002-10-15 Hoffmann La Roche Matrix-metalloprotease inhibitoren
AU1812197A (en) * 1996-03-01 1997-09-16 Sankyo Company Limited Hydroxamic acid derivatives
US6811995B1 (en) 1996-04-26 2004-11-02 Children's Medical Center Corporation Non-invasive enzyme screen for cancer
EP0900381A1 (en) * 1996-04-26 1999-03-10 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
US6462023B1 (en) 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
PL191366B1 (pl) 1996-09-10 2006-05-31 Vernalis Oxford Ltd Zastosowanie pochodnych kwasu hydroksamowego, pochodne kwasu hydroksamowego oraz kompozycje farmaceutyczne je zawierające
US6174915B1 (en) 1997-03-25 2001-01-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US6008243A (en) * 1996-10-24 1999-12-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
US20020099004A1 (en) * 1996-12-06 2002-07-25 Lund Leif Roge Inhibition of invasive remodelling
US5952320A (en) * 1997-01-07 1999-09-14 Abbott Laboratories Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion
ATE258063T1 (de) * 1997-03-03 2004-02-15 Darwin Discovery Ltd Selektive mmp inhibitoren mit verringerten nebenwirkungen
US5985900A (en) * 1997-04-01 1999-11-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
GB9707333D0 (en) * 1997-04-11 1997-05-28 British Biotech Pharm Metalloproteinase inhibitors
AU1110799A (en) * 1997-10-29 1999-05-17 Warner-Lambert Company Method of inhibiting metastases of cancer cells
KR100385662B1 (ko) 1998-01-09 2003-05-28 화이자 인코포레이티드 매트릭스 메탈로프로테아제 억제제
GB9803005D0 (en) 1998-02-12 1998-04-08 British Biotech Pharm Anti-inflammatory agents
US6329418B1 (en) 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
US6696456B1 (en) * 1999-10-14 2004-02-24 The Procter & Gamble Company Beta disubstituted metalloprotease inhibitors
JP2003528078A (ja) * 2000-03-21 2003-09-24 ザ プロクター アンド ギャンブル カンパニー 炭素環式側鎖を含有するメタロプロテアーゼ阻害剤
IL151250A0 (en) * 2000-03-21 2003-04-10 Procter & Gamble Difluorobutyric acid metalloprotease inhibitors
KR20020081465A (ko) * 2000-03-21 2002-10-26 더 프록터 앤드 갬블 캄파니 헤테로시클릭 측쇄 함유, ｎ-치환된 메탈로프로테아제저해제
AR036053A1 (es) 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
ATE360014T1 (de) 2001-06-15 2007-05-15 Vicuron Pharm Inc Bicyclische pyrrolidinverbindungen
CA2509060A1 (en) * 2002-12-27 2004-07-22 Angiotech International Ag Compositions and methods of using collagen and mmpi

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
DE69108529T2 (de) * 1990-12-03 1995-11-30 Celltech Therapeutics Ltd Peptidylderivate.

Also Published As

Publication number Publication date
US5714491A (en) 1998-02-03
ES2134939T3 (es) 1999-10-16
CA2139128A1 (en) 1994-11-10
ATE182137T1 (de) 1999-07-15
DE69419473T2 (de) 2000-03-16
EP0648205B1 (en) 1999-07-14
JPH08500124A (ja) 1996-01-09
AU6575394A (en) 1994-11-21
EP0648205A1 (en) 1995-04-19
WO1994025434A1 (en) 1994-11-10
DE69419473D1 (de) 1999-08-19

Similar Documents

Publication Publication Date Title
ZA948169B (en) Peptidyl derivatives and processes for their preparation
SI0959888T1 (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
MX9709915A (es) Heterociclos de peptidilo y composiciones que los contienen, utiles en el tratamiento de trastornos relacionados con trombina, y uso de los mismos.
NZ337211A (en) Method of treating inflammatory, HIV diseases by using peptidyl boronic acid ester and acid compounds as proteasome inhibitors
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
AU2713500A (en) Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
PL326700A1 (en) Sulphonamide-based inhibitors of intercellular substance metaloproteinases
HU905854D0 (en) New peptidase and isomerase inhibitors
PL310476A1 (en) Application of lamotrigin in treating neuro-aids diseases
EP0793660A4 (en) 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
AU5324598A (en) A method and product for cleaning and/or whitening of teeth
NZ331484A (en) Serine protease inhibitors having an alkynylamino side chain for use in treatment of thrombin related diseases
YU49422B (sh) Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću
BR9917495A (pt) Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores
AU8438798A (en) Use of draflazine-analogues for treating pain
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
TR199801887A2 (xx) Bir Na+/H+ - de�i�tiricisi inhibit�r�.
ATE179987T1 (de) Vitamin b 12-haltige sanddornkonzentrate oder - extrakte
AU2651692A (en) Use of aqueous solutions containing peroxobisulphate ions for the treatment of malignant cells
DE69003532T2 (de) Therapeutische zusammensetzung und kit für die behandlung der rheumatischen polyarthritis.